Maravai LifeSciences (NASDAQ: MRVI) reported Q3 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $41.6 million versus the consensus estimate of $49.04 million.

For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.